Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 231348, 2 pages

Omics Technologies and Neovascular Ocular Disorders

1Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
2 Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA
3Institute of Medical Genetics, Department of Obstetrics and Gynecology, University Medical Centre, Zaloška 2, 1000 Ljubljana, Slovenia
4Department of Ophthalmology, University of Szeged, Szeged 6700, Hungary

Received 11 May 2014; Accepted 11 May 2014; Published 26 May 2014

Copyright © 2014 Daniel Petrovič et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin Epidemiological Study of Diabetic Retinopathy: a review,” Diabetes/Metabolism Reviews, vol. 5, no. 7, pp. 559–570, 1989. View at Google Scholar · View at Scopus
  2. M. Globočnik Petrovič, P. Korošec, M. Košnik et al., “Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy,” Molecular Vision, vol. 14, pp. 1382–1387, 2008. View at Google Scholar · View at Scopus
  3. A.-J. F. Carr, M. J. K. Smart, C. M. Ramsden, M. B. Powner, L. da Cruz, and P. J. Coffey, “Development of human embryonic stem cell therapies for age-related macular degeneration,” Trends in Neurosciences, vol. 36, no. 7, pp. 385–395, 2013. View at Publisher · View at Google Scholar · View at Scopus